A new approach to treating breast tumours is in the early stages of
clinical trials in America. Afimoxifene is a a gel treatment being tested at
Northwestern University near Chicago after an encouraging study in France.
The new trial will look at six weeks’ use before breast cancer surgery. The
scientists hope this gel will reduce the side effects of some other treatments,
as up to nine times less of the drug will be absorbed into the bloodstream.

Read more about Afimoxifene here.